BEIJING–(BUSINESS WIRE)– Genetron Holdings Limited (“Genetron Health”), a China-based precision oncology company that covers full-cycle cancer care, announced that it has joined forces with DARUI. The partnership will support DARUI at developing pathogenic microorganism detection products and applying for registration of reagent kits using the NGS sequencer GENETRON S5 (Registration Number 20193220820). Featuring diverse application […]
Lexogen and BlueBee have launched a new, web-based data analysis portal to provide a more user‑friendly experience for Lexogen kit users analyzing RNA sequencing data. With the Lexogen web solution configuration on the BlueBee Genomics Platform, data upload is easier than ever— files can be uploaded with a simple “drag and drop” function (Figure 1) […]
CHOSOURCE platform to be combined with Rentschler Biopharma’s novel in-house cell line development process to provide speed, stability and high yield Laupheim, Germany; Milford, MA, USA and Cambridge, UK: Rentschler Biopharma SE, a world-class contract development and manufacturing organization (CDMO) for biopharmaceuticals, and Horizon Discovery, a global leader in the application of gene editing and […]
SAN DIEGO– Illumina, Inc. (NASDAQ: ILMN) is committed to supporting the global, national and local relief efforts of our customers, employees and communities, as we unite to combat COVID-19. Giving back is in our DNA, and together with the Illumina Corporate Foundation, we have committed more than $10M to support the communities where we live […]
North Carolina location will offer unmatched turnaround time and product options to support researchers in the region CORALVILLE, Iowa – Integrated DNA Technologies (IDT), a leading comprehensive genomics solutions provider, announced the opening of its new manufacturing facility located in the Research Triangle Park in North Carolina. The facility expands IDT’s manufacturing capabilities and will offer […]
Genetic susceptibility to coronavirus to be tested in ground-breaking nationwide study Genomes of thousands of patients with coronavirus will be sequenced to understand how a person’s genetic makeup could influence how they react to the virus Genomics England partners with University of Edinburgh to lead research drive to support the search for new treatment Thousands […]
By disrupting the expression of a particular gene and observing how this change affects expression of other genes, researchers can learn about the cellular roles of the disrupted gene. New technologies such as Perturb-seq offer unprecedented detail and depth of insight from such genetic disruption studies, but technical and practical hurdles have limited use of […]
– KAPA HyperExome is a state-of-the-art whole exome research panel with improved performance over the on-market SeqCap portfolio, providing improved coverage and uniformity – The KAPA Target Enrichment portfolio empowers clinical researchers to process more samples successfully while optimizing sequencing efficiency – When linked with KAPA library prep, the portfolio can reduce turnaround time for […]
Aldevron Appoints James Brown, Ph.D. President of Research Grade Nucleic Acids Business Unit FARGO, N.D. — Aldevron, the leading plasmid DNA manufacturing company, has expanded its leadership team by appointing Dr. James Brown President of its Research Grade nucleic acids business unit. Dr. Brown will oversee Aldevron’s strategy to provide plasmids and other nucleic acids […]
Merck KGaA, Darmstadt, Germany today announced that two of its Life Science business’ CRISPR-assisted genome-editing patents have been allowed in the United States. Technology provides more tools to fight difficult-to-treat diseases Life Science business actively licensing its CRISPR-Cas9 technology for therapeutic and other uses Committed to ethical use of genome-editing technology Merck KGaA, Darmstadt, Germany, […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
